With a promising route of administration, Cerebral Therapeutics offers a new approach to managing neurological diseases by means of delivering ideal dosing to targeted sites within the brain. 

Initially, Cerebral Therapeutics is focused on improving outcomes for patients with refractory epilepsy by targeting the site of the seizure generation and propagation in the brain.

Future cerebral therapeutic areas include obesity, Alzheimer’s disease, Parkinson’s disease, anxiety spectrum disorder and brain cancer.